Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,232 | -4,644 | -3,905 | -2,436 | -1,037 |
| Depreciation Amortization | 1 | 5 | 4 | 3 | 1 |
| Accounts receivable | 6 | 0 | -12 | 11 | 4 |
| Other Working Capital | -284 | -287 | 127 | 87 | -201 |
| Other Operating Activity | 253 | 529 | 496 | 363 | 255 |
| Operating Cash Flow | $-1,255 | $-4,397 | $-3,290 | $-1,973 | $-977 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -87 | -90 | N/A | N/A |
| Common Stock Issued | 1,225 | 5,238 | 5,433 | 1,950 | 1,970 |
| Financing Cash Flow | $1,225 | $5,151 | $5,343 | $1,950 | $1,970 |
| Beginning Cash Position | 1,337 | 549 | 568 | 530 | 538 |
| End Cash Position | 1,307 | 1,304 | 2,621 | 507 | 1,531 |
| Net Cash Flow | $-30 | $754 | $2,053 | $-22 | $993 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,255 | -4,397 | -3,290 | -1,973 | -977 |
| Free Cash Flow | -1,255 | -4,397 | -3,290 | -1,973 | -977 |